Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2015-02-24
Product name
Cy3-Streptavidin
CAS No.
26628-22-8
1.2.1 Relevant identified uses
Use in laboratories
supplier name
GE Healthcare UK Ltd
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
msdslifesciences@ge.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
1272/2008]
Product definition
Mixture
CLP CLASSIFICATION
Resp. Sens. 1, H334 Skin Sens. 1, H317 Aquatic Chronic 3, H412 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. Ingredients of unknown toxicity
Ingredient(s) with unknown acute toxicity
5%
Ingredients of unknown ecotoxicity
Percentage of the mixture consisting of ingredient(s) of unknown hazards to the aquatic environment: 5%
EU Classification
Directive 1999/45/EC [DPD] The product is classified as dangerous according to Directive 1999/45/EC and its amendments.
2.1 Classification of the substance or mixture
Xn; R22 R42/43 R52/53
Health hazards
Harmful if swallowed. May cause sensitisation by inhalation and skin contact.
Environmental hazards
Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. See Section 16 for the full text of the R phrases or H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
Signal word
Danger
Hazard statements
May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction. Harmful to aquatic life with long lasting effects.
Prevention
Wear protective gloves. Avoid release to the environment. Avoid breathing dust.
Response
IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or physician.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with Not applicable. child-resistant fastenings
Tactile warning of danger
Not applicable.
2.3 Other hazards
Other hazards which do not result None known. in classification
